Skip to content
stoqly
en · USD

Appearance

Language

Currency

Popular

All currencies

Data is in US dollars, converted at the exchange rate of Oct 28, 2026.

Sign in

Matt Zuga

CFO & Chief Business Officer, Acumen Pharmaceuticals, Inc.

Bought, 12 months
$0.0M
Sold, 12 months
$0.0M
Companies
1
Latest trade
Jan 22, 2026

Companies

Acumen Pharmaceuticals, Inc.CFO & Chief Business Officer −$0.0M

Trades

ABOS Sold 1,687 shares at $1.86 · planned $0.0M Jan 22 Form 4
ABOS Sold 2,473 shares at $1.81 · planned $0.0M Jan 21 Form 4
ABOS Sold 6,888 shares at $1.82 · planned $0.0M Jan 8 Form 4
ABOS Sold 5,805 shares at $2.00 · planned $0.0M Jan 7 Form 4
ABOS Sold 5,100 shares at $1.97 · planned $0.0M Jan 6 Form 4
ABOS Sold 4,000 shares at $1.96 · planned $0.0M Jan 5 Form 4

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.

↑ ↓ to move · ↵ to open